Specific and nonspecific macromolecule–drug conjugates for the improvement of cancer chemotherapy

This publication has 21 references indexed in Scilit:

• Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantation
  Nature, 1982
• A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
  Proceedings of the National Academy of Sciences, 1982
• Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells
  Nature, 1981
• Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A
  Nature, 1980
• Preparation and biological properties of a covalent antitumor drug—arm—carrier (DAC conjugate)
  FEBS Letters, 1980
• Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.
  Proceedings of the National Academy of Sciences, 1980
• Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells
  Proceedings of the National Academy of Sciences, 1978
• Melanotropin–daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells
  Nature, 1977
• Concanavalin A as a carrier of daunomycin
  Nature, 1977
• Suppression of tumour growth in mice by a drug–antibody conjugate using a novel approach to linkage
  Nature, 1975